Non-invasive prenatal diagnostic test for Down's Syndrome
Mundy L, Hiller JE
Record ID 32012000229
English
Authors' recommendations:
The isolation of foetal RNA and DNA from maternal blood appears to be feasible for the non-invasive diagnosis of Down's Syndrome. Both tests need to be optimised for their routine use in prenatal testing and large-scale studies should be conducted. Therefore HealthPACT recommended that this technology be monitored for further information in 12-months time.
Details
Project Status:
Completed
Year Published:
2008
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Down Syndrome
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.